Company Profiles

driven by the PitchBook Platform

NinePoint Medical

NinePoint Medical
2008 FOUNDED
PRIVATE STATUS
61-70 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$30.7M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of real time pathology devices designed to offer vivo imaging to create high-quality products that improve patient care. The company's real time pathology devices are used as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and may be used to mark areas of tissue, enabling physicians to make accurate diagnosis and more effective therapy for their patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • 12 Oak Park Drive
  • Bedford, MA 01730
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NinePoint Medical’s full profile, request a free trial.

NinePoint Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 25-Nov-2015 $30.7M 00000 00000 Completed Generating Revenue
6. Debt - General 09-Feb-2015 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 20-Mar-2014 000.00 000.00 000.00 Completed Generating Revenue
4. Senior Debt 31-Mar-2013 000 0000 Completed Startup
3. Grant 03-Nov-2010 00000 0000 Completed Startup
2. Early Stage VC (Series A) 14-Oct-2010 $33M $33M 000.00 Completed Startup
1. Seed Round 01-Jan-2008 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NinePoint Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 30,819,616 $0.010000 $0.05 $0.6 $0.6 1x $0.6 16.41%
Series A 15,200,000 $0.010000 $0.08 $1 $1 1x $1 8.09%
To view this company’s complete Cap Table, request access »

NinePoint Medical Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Dongsheng Accelerator Other Minority 000 0000 000000 0
GreyBird Ventures Venture Capital Minority 000 0000 000000 0
Hendale Capital Growth/Expansion Minority 000 0000 000000 0
Corning Corporation Minority 000 0000 000000 0
Partners HealthCare Innovation Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

NinePoint Medical Executive Team (11)

Name Title Board
Seat
Contact
Info
Christopher von Jako Ph.D Chief Executive Officer, President and Board Member
Judith Huber Chief Financial Officer
Heather Reed Vice President Quality & Regulatory Affairs and Compliance Officer
Michael Jesi Senior Director, Manufacturing and Operations
Patrick MacCarthy Vice President of Clinical Affairs & Marketing

4 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

NinePoint Medical Board Members (9)

Name Representing Role Since Contact
Info
Christopher von Jako Ph.D NinePoint Medical Chief Executive Officer, President and Board Member 000 0000
Curt Weinstein Corning Board Member 000 0000
Eric Swanson Self Board Member 000 0000
Henry Lee Hendale Capital Board Member 000 0000
Mark Levin Third Rock Ventures Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »